- Home
- BCYC vs RXST Comparison
BCYC vs RXST Comparison
Compare BCYC & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCYC
- RXST
- Stock Information
- Founded
- BCYC 2009
- RXST 1997
- Country
- BCYC United Kingdom
- RXST United States
- Employees
- BCYC N/A
- RXST N/A
- Industry
- BCYC Biotechnology: Pharmaceutical Preparations
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BCYC Health Care
- RXST Health Care
- Exchange
- BCYC Nasdaq
- RXST Nasdaq
- Market Cap
- BCYC 1.7B
- RXST 2.0B
- IPO Year
- BCYC 2019
- RXST 2021
- Fundamental
- Price
- BCYC $13.34
- RXST $30.39
- Analyst Decision
- BCYC Buy
- RXST Strong Buy
- Analyst Count
- BCYC 9
- RXST 8
- Target Price
- BCYC $34.50
- RXST $58.13
- AVG Volume (30 Days)
- BCYC 417.9K
- RXST 771.0K
- Earning Date
- BCYC 02-18-2025
- RXST 02-26-2025
- Dividend Yield
- BCYC N/A
- RXST N/A
- EPS Growth
- BCYC N/A
- RXST N/A
- EPS
- BCYC N/A
- RXST N/A
- Revenue
- BCYC $36,898,000.00
- RXST $128,293,000.00
- Revenue This Year
- BCYC $40.69
- RXST $60.30
- Revenue Next Year
- BCYC N/A
- RXST $33.85
- P/E Ratio
- BCYC N/A
- RXST N/A
- Revenue Growth
- BCYC 48.60
- RXST 67.52
- 52 Week Low
- BCYC $12.17
- RXST $26.29
- 52 Week High
- BCYC $28.67
- RXST $66.54
- Technical
- Relative Strength Index (RSI)
- BCYC 34.88
- RXST 30.12
- Support Level
- BCYC $13.20
- RXST $30.09
- Resistance Level
- BCYC $15.43
- RXST $31.92
- Average True Range (ATR)
- BCYC 0.89
- RXST 1.86
- MACD
- BCYC 0.16
- RXST -0.06
- Stochastic Oscillator
- BCYC 6.17
- RXST 37.82
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The Company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.